Advertisement

Topics

Companies Related to "Study of Treatment of Depression in Refractory Asthma" [Most Relevant Company Matches] [Advanced Search Results] RSS

19:43 EDT 18th March 2019 | BioPortfolio

Here are the most relevant search results for "Study of Treatment of Depression in Refractory Asthma" found in our extensive corporate database of over 50,000 company records.

Showing "Study Treatment Depression Refractory Asthma" Companies 1–25 of 4,000+

Relevant

DACOGEN

DACOGEN is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British (FAB) subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and i...


Atlanta Allergy and Asthma Clinic

Atlanta Allergy and Asthma Clinic is the premier facility in the Southeast for the treatment of allergy, asthma, and immunologic diseases. We know that living with the symptoms of allergy and asthma can range from being annoying to potentially life threatening. That is why our entire focus is on you our patient. From research, to prevention, to the latest in treatment options, our goal is helping ...

FEIGER HEALTH RESEARCH CENTER

The FEIGER HEALTH RESEARCH CENTER (FHRC) is a privately owned research facility in Wheat Ridge, Colorado. FHRC was founded in 1982 by Alan Feiger, M.D. Dr. Feiger was motivated by his desire to see more effective medications for the treatment of depression become available to the public. This can only happen by testing the new [investigational] medications on human subjects, in so-called Clinical ...


Cyberonics Sorin

Cyberonics, Inc. is a medical device company with core expertise in neuromodulation. The company developed and markets the VNS Therapy® System, which is FDA-approved for the treatment of medically refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses an implanted medical device that delivers pulsed electrical signals to the...

Asthmatx Inc.

Asthma is one of the most common and costly diseases in the world. The prevalence of asthma has grown in recent decades, and there is no cure. According to the Asthma and Allergy Foundation of America (AAFA), more than 20 million Americans have asthma, and managing asthma consumes over $18 billion of healthcare resources each year. In the U.S. each year, asthma attacks result in approximately 10 m...

Asthmatx, Inc.

Asthma is one of the most common and costly diseases in the world. The prevalence of asthma has grown in recent decades, and there is no cure. According to the Asthma and Allergy Foundation of America (AAFA), more than 20 million Americans have asthma, and managing asthma consumes over $18 billion of healthcare resources each year. In the U.S. each year, asthma attacks result in approximately 10 m...

Sierra Neuropharmaceuticals, Inc.

Sierra Neuropharmaceuticals is a biopharmaceutical company focused on the development and commercialization of centrally-administered, small molecule therapeutics for the treatment of severe CNS diseases refractory to oral medications. These include epilepsy, schizophrenia, bipolar disorder, anxiety disorders and major depression. The company uses a proprietary drug development process to refo...

Cyberonics, Inc.

Cyberonics, Inc. (NASDAQ:CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers pulsed electrical signals to the...

CerebralRx

Based in Yehud, Israel, CerebralRx was founded in 2010 as a spin-off of BioControl Medical to develop breakthrough implantable neuromodulation systems for the treatment of autonomic nervous system-related neurological disorders. The company’s flagship product is the FitNeS system, an implantable vagus nerve stimulation device for treating patients wit...

Allergy & Asthma Associates of Northern California

Asthma patients may be treated by primary care physicians, by asthma specialists, or by a combination of health care providers. Until recently, the question of who achieves the best outcomes at less cost has been poorly answered with miscellaneous data, anecdotal evidence, untested assumptions and educated guesses. A growing number of published clinical data states that the involvement of speciali...

NeuroRx, Inc.

NeuroRx, Inc. is a privately funded, clinical-stage pharmaceutical company, developing NRX-101, the first oral therapeutic for the treatment of Acute Suicidal Ideation and Behavior (ASIB) in bipolar depression. NeuroRx draws upon 30 years of basic science and clinical expertise in the role of the N-methyl-D-aspartate (NMDA), a receptor that regulates human...

COPD Foundation

Chronic Obstructive Pulmonary Disease (COPD) is the fourth leading cause of death in the U.S. and the only chronic disease growing in mortality. It affects approximately 24 million Americans but only 12 million are diagnosed. COPD includes chronic bronchitis, emphysema, and adult onset (refractory) asthma. Symptoms include breathlessness, wheezing, and chr...

Inflazyme Pharmaceuticals Ltd.

Inflazyme Pharmaceuticals is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies for the treatment of respiratory and inflammatory diseases. Our core focus is medicinal chemistry based, orally active, small molecules aimed at treating unmet medical needs.Our most advanced product, IPL512,602, is on track to enter a phase IIb clinical stud...

Asthmacure.com

Asthmacure.com is a free webresource on asthma disease. Asthmacure.com is an offering by Indian Asthma Care Society for providing useful information and tips for asthma patients, their family members and friends. Indian Asthma Care Society is a leading non-profit organization of India that strives to spread knowledge in the society by educating people on asthma and smoking. We achieve our goals on...

Verastem Oncology

Verastem, Inc. (Nasdaq:VSTM), operating as Verastem Oncology, is a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients. Verastem Oncology is currently developing duvelisib, a dual inhibitor of PI3K-delta and PI3K-gamma, which has successfully met its primary endpoint i...

Corcept Therapeutics

Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the development of drugs for the treatment of severe psychiatric and neurological diseases. Our lead product, CORLUX, is currently in three Phase 3 clinical trials for the treatment of the psychotic features of psychotic major depression (PMD), a disorder that affects approximately three million adults in the United States ea...

bluebird bio, Inc. bluebird bio to Present Updated Clinical Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti- BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASCO Annual Meeting

Vivus

VIVUS, Inc. is a pharmaceutical company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health. Analysts speculate that the potential market for obesity ranges from $5 billion to $10 billion annually, and the indications targeted by VIVUS' sexual health products each represent a projected market greater than $1 billion annual...

Cyberonics Incorporated

Cyberonics, Inc. (NASDAQ: CYBX) pioneered the Vagus Nerve Stimulation (VNS Therapy™) System. Founded in 1987 to design, develop and market implantable medical devices for the treatment of epilepsy and other debilitating neurological disorders, Cyberonics has emerged as a leader in the neuromodulation industry. The VNS Therapy System uses a surgically implanted medical device that delivers elec...

Aerocrine Inc

Aerocrine is a clinically based medical, technical company with headquarters in Stockholm, Sweden. It was founded in 1997 by scientists at the Karolinska Institute that first identified Nitric Oxide (NO) as a marker of inflammation. Aerocrine’s initial commitment is to develop NO analysis for asthma. The company holds a comprehensive patent portfolio in prioritized markets such as the European U...

Roche Biosciences

Today Roche Bioscience researchers are focused on the discovery and delivery of new medicines to treat the following diseases:Alzheimer's disease HIV/AIDS Arthritis Incontinence Asthma Osteoporosis Anxiety Overactive bladder Auto-immune disorders Benign prostatic hyperplasia Depression Pelvic hypersensitivity Emphysema and chronic bronchitis Schizophrenia Hepatitis C

TxCell

TxCell, a spin-off of Inserm (France’s National Institute for Health and Medical Research) is located in the Sophia Antipolis technology park, Nice, France. It is developing innovative personalized cell-based immunotherapies for the treatment of severe chronic inflammatory diseases with high medical need using its unique and proprietary technology platform based on the properties of autolo...

Heal Asthma

Herbal Medicine for Asthma Cure

1-800-GOT-MOLD?

1-800-GOT-MOLD? is America’s leading indoor air quality company specializing in residential mold inspections, mold testing and mold remediation consulting. Because medical studies show clear links between mold and chronic sinusitis, asthma, allergies and even depression, the company’s focus is on its customers’ health. Located in Tampa, Florida, ...

CyDex, Inc.

CyDex, Inc. is developing and commercializing specialty pharmaceutical products with significant advantages based on our innovative drug delivery technologies.CyDex is conducting preclinical and clinical studies to advance a promising pipeline of oral, parenteral and inhaled drug candidates. These products are designed to address unmet needs in asthma, depression, allergy, cancer, arrhythmia and o...


More From BioPortfolio on "Study of Treatment of Depression in Refractory Asthma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks